Cigna Group (NYSE:CI) Shares Sold by Choreo LLC

Choreo LLC lowered its stake in Cigna Group (NYSE:CI - Free Report) by 9.0% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 10,169 shares of the health services provider's stock after selling 1,001 shares during the quarter. Choreo LLC's holdings in Cigna Group were worth $3,346,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Wayfinding Financial LLC bought a new stake in Cigna Group during the first quarter worth approximately $40,000. Putney Financial Group LLC bought a new position in shares of Cigna Group during the 4th quarter valued at approximately $36,000. Transce3nd LLC purchased a new stake in Cigna Group during the 4th quarter valued at $38,000. Ameriflex Group Inc. bought a new stake in Cigna Group in the fourth quarter worth $44,000. Finally, Heck Capital Advisors LLC purchased a new position in Cigna Group during the fourth quarter worth $53,000. Institutional investors own 86.99% of the company's stock.

Cigna Group Stock Up 0.8%

Shares of NYSE CI traded up $2.43 during mid-day trading on Friday, reaching $296.36. 1,325,699 shares of the company were exchanged, compared to its average volume of 1,724,874. Cigna Group has a 1 year low of $262.03 and a 1 year high of $370.83. The firm has a 50-day moving average of $312.53 and a 200 day moving average of $312.10. The stock has a market cap of $79.17 billion, a price-to-earnings ratio of 16.41, a P/E/G ratio of 0.89 and a beta of 0.44. The company has a quick ratio of 0.72, a current ratio of 0.72 and a debt-to-equity ratio of 0.65.

Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings results on Friday, May 2nd. The health services provider reported $6.74 EPS for the quarter, beating the consensus estimate of $6.35 by $0.39. Cigna Group had a net margin of 1.97% and a return on equity of 18.63%. The business had revenue of $65.45 billion during the quarter, compared to analyst estimates of $60.39 billion. During the same period in the prior year, the firm posted $6.47 earnings per share. The company's quarterly revenue was up 14.4% on a year-over-year basis. On average, research analysts expect that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 18th. Investors of record on Thursday, September 4th will be given a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a yield of 2.04%. The ex-dividend date is Thursday, September 4th. Cigna Group's dividend payout ratio is currently 33.44%.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on the stock. Wall Street Zen downgraded shares of Cigna Group from a "strong-buy" rating to a "buy" rating in a research note on Friday, July 18th. Robert W. Baird reduced their price objective on shares of Cigna Group from $388.00 to $362.00 and set an "outperform" rating on the stock in a research report on Tuesday, April 15th. Mizuho boosted their target price on Cigna Group from $360.00 to $384.00 and gave the company an "outperform" rating in a research report on Wednesday, April 9th. TD Cowen raised Cigna Group to a "strong-buy" rating in a research note on Monday, June 23rd. Finally, Morgan Stanley raised their price target on Cigna Group from $379.00 to $390.00 and gave the stock an "overweight" rating in a research note on Monday, May 5th. Two equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, Cigna Group has an average rating of "Buy" and an average price target of $380.39.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.